Inactive

NOI-NIAID-2133446 **NOTICE OF INTENT NAICS – 518210, Data Processing, Hosting and Related Services (for Dataset Deliverables) This is a Notice of Intent, not a request for proposal. The National Insti... NOI-NIAID-2133446 **NOTICE OF INTENT NAICS – 518210, Data Processing, Hosting and Related Services (for Dataset Deliverables) This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Gryphon Scientific, LLC, of Takoma Park, MD, to procure two deliverable datasets as they relate to COVID-19 impacts for a study titled “Quantitative analysis of the availability, quality, and reliability of infectious disease data in preprint manuscripts and their use in policy development". This acquisition includes the following items and requirements: Deliverable 1: database of synthesized disease literature, including preprints, peer-reviewed literature, and policy Deliverable 2: manuscript ready for submission to a peer-reviewed journal, no more than one year from the start of the effort The NIAID Laboratory of Clinical Immunology and Microbiology (LCIM) conducts clinical and basic science, and epidemiologic research into human immunologic, inflammatory, and infectious diseases. This requirement is needed in support of a specialized project "Quantitative analysis of the availability, quality, and reliability of infectious disease data in preprint manuscripts and their use in policy development". Gryphon Scientific is a specialized research and consulting practice composed of life scientists and health researchers who use rigorous scientific analyses to address problems of global health and security. They include a core group of physical and life scientists skilled in quantitative and qualitative analytics. Their scientists have high levels of government, military, executive agency, and private sector experience. The combination of innovative analytics and practical field experience uniquely positions them to solve complex problems affecting public health and safety. Gryphon Scientific has been actively involved in infectious disease and policy research and will be able to leverage their prior work to support NIAID’s needs for this acquisition. Specifically, they were responsible for critically evaluating and synthesizing published research and media reports on COVID-19 to inform government decision-making and policy development. This is a proprietary database that is not publicly available be reviewed and expanded for this acquisition and then utilized for quantitative analysis of how preprints impacted policy during the COVID-19 pandemic. The statutory authority for this sole source requirement is 41 U.S.C. 1901 (e) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-2133446) to Dana Monroe at dana.monroe@nih.gov, by Wednesday, August 3, 2022, by 5:00pm EDT. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.